Flovent and Cefotaxime drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Flovent (fluticasone propionate) and Cefotaxime (cefotaxime sodium). Common drug interactions include cardiogenic shock among females and haemolysis among males.

The phase IV clinical study analyzes what interactions people have when they take Flovent and Cefotaxime. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Flovent?

Flovent has active ingredients of fluticasone propionate. It is often used in asthma. eHealthMe is studying from 44,817 Flovent users. Check the latest studies of Flovent.

What is Cefotaxime?

Cefotaxime has active ingredients of cefotaxime sodium. eHealthMe is studying from 7,559 Cefotaxime users. Check the latest studies of Cefotaxime.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 28, 2026

18 people who take Flovent and Cefotaxime together, and have interactions are studied.

Flovent and Cefotaxime drug interactions.

What are the common drug interactions of Flovent and Cefotaxime, by gender? *:

female:

  1. Cardiogenic shock (inadequate circulation of blood)
  2. Congestive cardiomyopathy (weakening of heart muscle)
  3. Respiratory failure (inadequate gas exchange by the respiratory system)
  4. Hypotension (abnormally low blood pressure)
  5. Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
  6. Anaemia (lack of blood)
  7. Apgar score low
  8. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  9. Chest pain
  10. Chorioamnionitis (inflammation of the fetal membranes (amnion and chorion) due to a bacterial infection)

male:

  1. Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid)
  2. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  3. Pneumonia
  4. Pulmonary embolism (blockage of the main artery of the lung)
  5. Respiratory distress (difficulty in breathing)
  6. Respiratory tract oedema (swelling of respiratory tract due to excess fluid collection in tissue)
  7. Streptococcal bacteraemia (a bacterial infection of blood)
  8. Tonsillar disorder (disease of tonsil)
  9. Tooth infection
  10. Aspartate aminotransferase increased

What are the common drug interactions of Flovent and Cefotaxime, by age (0-1 to 60+)? *:

0-1:

  1. Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
  2. Apgar score low
  3. Chorioamnionitis (inflammation of the fetal membranes (amnion and chorion) due to a bacterial infection)
  4. Funisitis (infection of the connective tissue of the umbilical cord)
  5. Genital haemorrhage (bleeding from genital)
  6. Hyperkalaemia (damage to or disease of the kidney)
  7. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  8. Hypotension (abnormally low blood pressure)
  9. Necrosis (the death of body tissue)
  10. Neonatal asphyxia (a condition in which an extreme decrease in the concentration of oxygen in the body accompanied by an increase in the concentration of carbon dioxide in neonate)

2-9:

  1. Altered state of consciousness (altered state of mind)
  2. Croup infectious (a loud cough that resembles the barking of a seal and difficulty breathing can transfer to other)
  3. Ear infection
  4. Hydrocephalus (water on the brain)
  5. Influenza
  6. Pleural effusion (water on the lungs)
  7. Respiratory tract infection
  8. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  9. Subdural haematoma (blood collects between the skull and the surface of the brain)
  10. Tonsillar disorder (disease of tonsil)

10-19:

  1. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  2. Endocarditis (inflammation in heart muscle)
  3. Fatigue (feeling of tiredness)
  4. Laryngomalacia (a congenital softening of the tissues of the larynx)
  5. Pericardial effusion (fluid around the heart)
  6. Pneumonia
  7. Pulmonary embolism (blockage of the main artery of the lung)
  8. Respiratory distress (difficulty in breathing)
  9. Respiratory tract oedema (swelling of respiratory tract due to excess fluid collection in tissue)
  10. Streptococcal bacteraemia (a bacterial infection of blood)

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Cardiogenic shock (inadequate circulation of blood)
  2. Congestive cardiomyopathy (weakening of heart muscle)
  3. Respiratory failure (inadequate gas exchange by the respiratory system)
  4. Chest pain
  5. Electrocardiogram abnormal
  6. Electrocardiogram st segment depression
  7. Hypotension (abnormally low blood pressure)
  8. Pneumonia
  9. Sepsis (a severe blood infection that can lead to organ failure and death)
  10. Tachycardia (a heart rate that exceeds the range of 100 beats/min)

60+:

  1. Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid)
  2. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  3. Leukocytosis (increased white blood cells)
  4. Low density lipoprotein increased (cholesterol increased in blood)
  5. Platelet count increased
  6. Blood bilirubin increased
  7. Haemoglobin decreased
  8. Aspartate aminotransferase increased
  9. Cold agglutinins positive
  10. Blood lactate dehydrogenase increased

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 3 people, 16.67%
  2. Hypersensitivity: 3 people, 16.67%
  3. Cardiac Enzymes Increased: 3 people, 16.67%
  4. Cough: 3 people, 16.67%
  5. Primary Immunodeficiency Syndrome: 2 people, 11.11%
  6. Wheezing (a high-pitched whistling sound made while you breath): 1 person, 5.56%
  7. Hydrocephalus (water on the brain): 1 person, 5.56%
  8. Ear Disorder: 1 person, 5.56%
  9. Drooling (drop saliva uncontrollably from the mouth): 1 person, 5.56%
  10. Decreased Bronchial Secretion: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Flovent and Cefotaxime?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Flovent and Cefotaxime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Flovent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cefotaxime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Flovent and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cefotaxime and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on fluticasone propionate and cefotaxime sodium (the active ingredients of Flovent and Cefotaxime, respectively), and Flovent and Cefotaxime (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: